7.30pm 11 August 2021
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the greatest healthcare challenge our world has faced in recent times.
Though primarily this virus affects the respiratory system, involvement of cardiovascular system with varying degrees of severity is quite common. Also, patients with preexisting cardiovascular disease have a much higher case fatality rate from COVID-19 infection compared to the standard population.
Management of cardiac complications secondary to COVID -19 and also concomitant presentation with cardiac illnesses during COVID-19 present new challenges in the management of such patients, many of whom will need emergency care in a timely manner. Also, the resource allocation and prioritisation of management related issues for such illnesses during these pandemic times will need careful consideration.
In this review the presenters will review the cardiac complication of COVID-19 and their implications on management from an Australian and International perspective. This will be followed by a panel discussion, which will include cardiovascular experts from India, where they will discuss more practical issues and also answer any questions from the audience.